Advertisement
News
Advertisement

Galenea wins $4.5M NIH grant

Sun, 10/17/2010 - 4:32am
Mass High Tech: The Journal of New England Technology

Cambridge biopharmaceutical firm Galenea Corp. has won a $4.5 million grant from the National Institute of Mental Health for a technology platform aimed at identifying compounds to treat schizophrenia. The grant, the second of its kind, is funded by the American Recovery and Reinvestment Act of 2009.

The grant was awarded for the company’s MANTRA (Multiwell, Automated NeuroTRansmission Assay) technology platform that Galenea reports has potential to treat other psychiatric and neurodegenerative diseases linked to synaptic transmission, the communication of brain neurons.

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading